SPECTRACEF Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Spectracef, and when can generic versions of Spectracef launch?
Spectracef is a drug marketed by Vansen Pharma and is included in one NDA.
The generic ingredient in SPECTRACEF is cefditoren pivoxil. There are six drug master file entries for this compound. Additional details are available on the cefditoren pivoxil profile page.
Summary for SPECTRACEF
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 51 |
Patent Applications: | 925 |
What excipients (inactive ingredients) are in SPECTRACEF? | SPECTRACEF excipients list |
DailyMed Link: | SPECTRACEF at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for SPECTRACEF
US Patents and Regulatory Information for SPECTRACEF
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vansen Pharma | SPECTRACEF | cefditoren pivoxil | TABLET;ORAL | 021222-001 | Aug 29, 2001 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Vansen Pharma | SPECTRACEF | cefditoren pivoxil | TABLET;ORAL | 021222-002 | Jul 21, 2008 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for SPECTRACEF
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Vansen Pharma | SPECTRACEF | cefditoren pivoxil | TABLET;ORAL | 021222-001 | Aug 29, 2001 | ⤷ Try a Trial | ⤷ Try a Trial |
Vansen Pharma | SPECTRACEF | cefditoren pivoxil | TABLET;ORAL | 021222-002 | Jul 21, 2008 | ⤷ Try a Trial | ⤷ Try a Trial |
Vansen Pharma | SPECTRACEF | cefditoren pivoxil | TABLET;ORAL | 021222-001 | Aug 29, 2001 | ⤷ Try a Trial | ⤷ Try a Trial |
Vansen Pharma | SPECTRACEF | cefditoren pivoxil | TABLET;ORAL | 021222-002 | Jul 21, 2008 | ⤷ Try a Trial | ⤷ Try a Trial |
Vansen Pharma | SPECTRACEF | cefditoren pivoxil | TABLET;ORAL | 021222-001 | Aug 29, 2001 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for SPECTRACEF
See the table below for patents covering SPECTRACEF around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Canada | 2234426 | COMPOSITION ANTIBACTERIENNE ADMINISTREE PAR VOIE ORALE (ANTIBACTERIAL COMPOSITION FOR ORAL ADMINISTRATION) | ⤷ Try a Trial |
Japan | H0364503 | ⤷ Try a Trial | |
Portugal | 862915 | ⤷ Try a Trial | |
Japan | S61178991 | NOVEL CEPHALOSPORIN COMPOUND | ⤷ Try a Trial |
Canada | 1272714 | COMPOSES DE CEPHALOSPORINE, ET LEUR PRODUCTION (CEPHALOSPORIN COMPOUNDS AND THE PRODUCTION THEREOF) | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |